TrendsWide
Contact US
  • Home
  • Trending
  • Health
  • Life Style
  • NBA
  • Reviews
No Result
View All Result
TrendsWide
  • Home
  • Trending
  • Health
  • Life Style
  • NBA
  • Reviews
No Result
View All Result
TrendsWide
No Result
View All Result
Home Uncategorized

Convalescent plasma therapy DOESN’T cut the risk of dying from Covid-19

by souhaib
October 23, 2020
in Uncategorized
0
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT



You might also like

Agile Time Management Project Management

Pfizer says it expects data on COVID-19 vaccines for children in ‘early part of 2021’

John Oliver on the new 'Last Week Tonight' season and if Trump was good for comedy

Convalescent plasma has been used to treat infections for at least a century, dating back to the 1918 Spanish flu pandemic.  

It was also trialed during the 2009-2010 H1N1 influenza virus pandemic, 2003 SARS epidemic, and the 2012 MERS epidemic. 

Convalescent plasma was used as a last resort to improve the survival rate of patients with SARS whose condition continued to deteriorate.

It has been proven ‘effective and life-saving’ against other infections, such as rabies and diphtheria, said Dr Mike Ryan, of the World Health Organization.

‘It is a very important area to pursue,’ Dr Ryan said.

Although promising, convalescent plasma has not been shown to be effective in every disease studied, the FDA say.

Is it already being used for COVID-19 patients?

Before it can be routinely given to patients with COVID-19, it is important to determine whether it is safe and effective through clinical trials.

The FDA said it was ‘facilitating access’ for the treatment to be used on patients with serious or immediately life-threatening COVID-19 infections’.

It came after New York Governor Andrew Cuomo said that plasma would be tested there to treat the sickest of the state’s coronavirus patients.  

COVID-19 patients in Beijing, Wuhan and Shanghai are being treated with this method, authorities report. 

Lu Hongzhou, professor and co-director of the Shanghai Public Health Clinical Centre, said in February the hospital had set up a special clinic to administer plasma therapy and was selecting patients who were willing to donate. 

‘We are positive that this method can be very effective in our patients,’ he said.

Meanwhile, the head of a Wuhan hospital said plasma infusions from recovered patients had shown some encouraging preliminary results.

The MHRA has approved the use of the therapy in the UK, but it has not been revealed which hospitals have already tried it. 

How does it work? 

Blood banks take plasma donations much like they take donations of whole blood; regular plasma is used in hospitals and emergency rooms every day.

If someone’s donating only plasma, their blood is drawn through a tube, the plasma is separated and the rest infused back into the donor’s body.

Then that plasma is tested and purified to be sure it doesn’t harbor any blood-borne viruses and is safe to use.

For COVID-19 research, people who have recovered from the coronavirus would be donating.  

Scientists would measure how many antibodies are in a unit of donated plasma – tests just now being developed that aren’t available to the general public – as they figure out what’s a good dose, and how often a survivor could donate.

There is also the possibility that asymptomatic patients – those who never showed symptoms or became unwell – would be able to donate. But these ‘silent carriers’ would need to be found via testing first.

Japanese pharmaceutical company Takeda is working on a drug that contains recovered patients antibodies in a pill form, Stat News reported. 

Could it work as a vaccine? 

While scientists race to develop a COVID-19 vaccine, blood plasma therapy could provide temporary  protection for the most vulnerable in a similar fashion. 

A vaccine trains people’s immune systems to make their own antibodies against a target germ. The plasma infusion approach would give people a temporary shot of someone else’s antibodies that are short-lived and require repeated doses.

If US regulator the FDA agrees, a second study would give antibody-rich plasma infusions to certain people at high risk from repeated exposures to COVID-19, such as hospital workers or first responders, said Dr Liise-anne Pirofski of New York’s Montefiore Health System and Albert Einstein College of Medicine.

That also might include nursing homes when a resident becomes ill, in hopes of giving the other people in the home some protection, she said.



Source link

Share this:

  • Twitter
  • Facebook
  • More
  • Pinterest
  • Telegram
  • Email
Tags: bbc healthdailymail heath
Share30Tweet19
Previous Post

‘Far-right plot to kill solicitor who defends UK migrants’

Next Post

Newcastle sign a former BRICKLAYER who is friends with Allan Saint-Maximin

souhaib

Recommended For You

Agile Time Management Project Management

by souhaib
March 19, 2021
0

Time management Project management is very important.  If you are an owner of the company often the CEO without being the managing director, the one who must be...

Read more

Pfizer says it expects data on COVID-19 vaccines for children in ‘early part of 2021’

by souhaib
February 11, 2021
0

Both Pfizer Inc and Moderna Inc say they expect to have data on how well their coronavirus vaccines work in teenagers later this year.Currently, immunizations against COVID-19 are...

Read more

John Oliver on the new 'Last Week Tonight' season and if Trump was good for comedy

by souhaib
February 11, 2021
0

John Oliver talked with USA TODAY TV Editor Gary Levin about the new season of "Last Week Tonight" and why he won't miss President Trump.        Source link

Read more

Dr Fauci declares April ‘open season’ for COVID-19 vaccinatoins

by souhaib
February 11, 2021
0

Dr Fauci declares April 'open season' for any American adult to get a COVID-19 vaccine and predicts the 'majority' of Americans will have two doses by fallDr Anthony...

Read more

Biden administration fears it could take nine months to reach herd immunity

by souhaib
February 11, 2021
0

The US may not reach herd immunity and return to some semblance of normalcy until Thanksgiving at the current pace of COVID-19 vaccinations and speed of variant spread,...

Read more
Next Post

Newcastle sign a former BRICKLAYER who is friends with Allan Saint-Maximin

No Result
View All Result

Recent Posts

  • Supreme Court ruling on abortion could jeopardize other rights
  • Moody’s says Russia defaulted on its debt
  • Middle East Eye: Demolishing Muslim homes in India is an Israeli-style war crime | Hurriyat News
  • Longtime TV Actor Mary Mara Dies In Apparent Drowning At Age 61
  • D.C. Is a Democratic Bastion. Republicans Could Ban Abortion There.

Browse by Category

  • Australia
  • Automotive
  • Business
  • Celebrity
  • Cryptocurrency
  • Deals
  • Economie
  • Education
  • Euro
  • Forex
  • Gaming
  • Health
  • Life Style
  • NBA
  • News
  • Reviews
  • Sports
  • Switzerland
  • Trending
  • U.S.
  • Uncategorized

Categories

  • Australia
  • Automotive
  • Business
  • Celebrity
  • Cryptocurrency
  • Deals
  • Economie
  • Education
  • Euro
  • Forex
  • Gaming
  • Health
  • Life Style
  • NBA
  • News
  • Reviews
  • Sports
  • Switzerland
  • Trending
  • U.S.
  • Uncategorized

Pages

  • Contact US
  • Newsletter
  • Privacy Policy
  • Terms & Conditions

© 2021 - TrendsWide

No Result
View All Result
  • Home
  • Contact US
  • Privacy Policy
  • Trending
  • U.S.
  • Economie
  • Deals
  • Reviews
  • Cryptocurrency
  • Health
  • Life Style
  • NBA

© 2021 - TrendsWide